GRAYZEL DAVID S. - Insider Non-Derivative Transactions at Aerovate Therapeutics, Inc. (AVTE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 9, 2024, GRAYZEL DAVID S.'s relationship to Aerovate Therapeutics, Inc. (AVTE) is Director, and currently has 14,502 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other AVTE insiders.
Data Source: SEC.
GRAYZEL DAVID S. - Insider Non-Derivative Transactions at AVTE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 10, 2024 | Sell -- (Common Stock) | 11882 | 28.15 | 14502 |